Procaine (Gerovital H3) Therapy: Mechanism of Inhibition of Monoamine Oxidase
- 1 August 1974
- journal article
- research article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 22 (8), 365-371
- https://doi.org/10.1111/j.1532-5415.1974.tb04843.x
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Gerovital H3 in the Treatment of the Depressed Aging PatientPsychosomatics, 1974
- The mechanism of action of the monoamine oxidase inhibitor pargylineLife Sciences, 1973
- AGEING, MONOAMINES, AND MONOAMINE-OXIDASE LEVELSThe Lancet, 1972
- Human liver mitochondrial monoamine oxidase. III. Kinetic studies concerning time-dependent inhibitionsBiochemistry, 1969
- Inhibition of Rabbit Liver Mitochondrial Monoamine Oxidase by New Hydrazine Derivatives. II. Probable Prosthetic Groups of the Enzyme, and Their Blocking by the Compound 31037-S or 31087-SCHEMICAL & PHARMACEUTICAL BULLETIN, 1969
- Purification and properties of monoamineoxidaseBiochimica et Biophysica Acta (BBA) - Specialized Section on Enzymological Subjects, 1963
- PHARMACOLOGIC STUDIES OF SOME NONHYDRAZINE MAO INHIBITORSAnnals of the New York Academy of Sciences, 1963
- Partial purification of monoamine oxidase from rat brainBiochimica et Biophysica Acta, 1962
- New Inhibitor of Monoamine OxidaseNature, 1960
- The Determination of Enzyme Dissociation ConstantsJournal of the American Chemical Society, 1934